AIM Schedule 1 - Feedback Plc (8919F)
2014年4月30日 - 5:41PM
RNSを含む英国規制内ニュース (英語)
TIDMFDBK
RNS Number : 8919F
AIM
30 April 2014
ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION
IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM
RULES")
------------------------------------------------------------------------------------------
COMPANY NAME:
------------------------------------------------------------------------------------------
Feedback plc (the "Company" or "Feedback")
------------------------------------------------------------------------------------------
COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY
TRADING ADDRESS (INCLUDING POSTCODES) :
------------------------------------------------------------------------------------------
26 Red Lion Square, London WC1R 4AG
------------------------------------------------------------------------------------------
COUNTRY OF INCORPORATION:
------------------------------------------------------------------------------------------
United Kingdom
------------------------------------------------------------------------------------------
COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED
BY AIM RULE 26:
------------------------------------------------------------------------------------------
www.fbk.com
------------------------------------------------------------------------------------------
COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR,
IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING
POLICY). IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE
TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED:
------------------------------------------------------------------------------------------
The acquisition of Cambridge Computed Imaging Limited ("CCI")
and TexRAD Limited ("TexRAD") will result in a reverse takeover
under AIM Rule 14. The business of the enlarged group, of
which the main country of operation will be the UK, will be
that of CCI and TexRAD.
CCI was formed in 2001 by former employees of the Department
of Radiology at Papworth Hospital (now Papworth Hospital NHS
Foundation Trust) to provide picture archiving and communication
systems (PACS) for the display, review, manipulation and archiving
of medical images. TexRAD was spun out from the University
of Sussex in 2011 and was established to develop textural
analysis tools for the detection and measurement of quantitative
imaging biomarkers within cancer tumours.
CCI specialises in providing software that helps doctors use
medical images in diagnosis and treatment. Since its foundation,
CCI has focused on supporting the needs of Papworth Hospital,
the UK's largest specialist cardiothoracic hospital, and other
facilities where its software is used to support diagnosis,
treatment planning, treatment response and knowledge sharing
within multi-disciplinary teams.
TexRAD offers an innovative quantitative tool to those researching
the diagnosis, prognosis and treatment response of cancer.
The technology enables quantitative textural analysis of heterogeneity
to be found in routinely acquired clinical diagnostic images
which could serve to risk stratify tumours and assist in response
evaluation. Research customers have shown that using TexRAD's
quantitative textural analysis, heterogeneity could further
add value to existing markers of tumour size, density and
perfusion as a quantitative imaging biomarker and potentially
assist in clinical decision making by optimising care pathways
for improved patient outcomes and provide cost-effective patient
management.
Both Tom Charlton and Trevor Brown are participating in the
Subscription. In addition, Tom Charlton is a shareholder in
CCI. The participation of Messrs Charlton and Brown in the
Subscription and Mr Charlton's entry into the CCI acquisition
agreement are related party transactions in accordance with
the AIM Rules.
------------------------------------------------------------------------------------------
DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS
AS TO TRANSFER OF THE SECURITIES (i.e. where known, number
and type of shares, nominal value and issue price to which
it seeks admission and the number and type to be held as treasury
shares):
------------------------------------------------------------------------------------------
190,746,746 ordinary shares of 0.25p per share.
There are no restrictions on the transfer of securities.
------------------------------------------------------------------------------------------
CAPITAL TO BE RAISED ON ADMISSION (IF APPLICABLE) AND ANTICIPATED
MARKET CAPITALISATION ON ADMISSION:
------------------------------------------------------------------------------------------
New capital to be raised on Admission to AIM: GBP300,000,
GBP260,000 of which is being subscribed for by directors of
the Company.
Anticipated market capitalisation: approximately GBP2.38 million.
------------------------------------------------------------------------------------------
PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION:
------------------------------------------------------------------------------------------
53.11%
------------------------------------------------------------------------------------------
DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH
THE AIM COMPANY HAS APPLIED OR AGREED TO HAVE ANY OF ITS SECURITIES
(INCLUDING ITS AIM SECURITIES) ADMITTED OR TRADED:
------------------------------------------------------------------------------------------
None
------------------------------------------------------------------------------------------
FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS
(underlining the first name by which each is known or including
any other name by which each is known):
------------------------------------------------------------------------------------------
Nicholas Nick Steven Shepheard (Chairman and Chief Executive)
Simon Gregory Barrell (Non-executive Director)
Trevor Edward Brown (Non-executive Director)
Thomas Tom William George Charlton (Non-executive Director)
------------------------------------------------------------------------------------------
FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED
AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE AND AFTER
ADMISSION (underlining the first name by which each is known
or including any other name by which each is known):
------------------------------------------------------------------------------------------
As at the date of this As at admission
announcement
Number of Percentage of Number of Percentage of
Ordinary Shares Existing Shares Ordinary Shares Issued Share
(%) Capital (%)
Trevor Edward
Brown 39,189,111 29.93 49,589,111 26.00
Thomas Tom
William George
Charlton 34,084,808 26.03 46,717,408 24.49
William Roy
Ruffler 9,397,893 7.18 12,597,893 6.60
Prof John
Westcott 5,999,287 4.58 5,999,287 3.15
Nicholas Nick
Shepheard 5,000,000 3.82 5,000,000 2.62
University of
Sussex 0 0.00 9,400,000 4.93
------------------------------------------------------------------------------------------
NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE
2, PARAGRAPH (H) OF THE AIM RULES:
------------------------------------------------------------------------------------------
None
------------------------------------------------------------------------------------------
(i) ANTICIPATED ACCOUNTING REFERENCE DATE
(ii) DATE TO WHICH THE MAIN FINANCIAL INFORMATION IN THE ADMISSION
DOCUMENT HAS BEEN PREPARED (this may be represented by unaudited
interim financial information)
(iii) DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS
PURSUANT TO AIM RULES 18 AND 19:
------------------------------------------------------------------------------------------
i) 31 May
ii) 30 November 2013
iii) 30 November 2014, 28 February 2015, 30 November 2015
------------------------------------------------------------------------------------------
EXPECTED ADMISSION DATE:
------------------------------------------------------------------------------------------
19 May 2014
------------------------------------------------------------------------------------------
NAME AND ADDRESS OF NOMINATED ADVISER:
------------------------------------------------------------------------------------------
Sanlam Securities UK Limited,10 King William Street, London
EC4N 7TW
------------------------------------------------------------------------------------------
NAME AND ADDRESS OF BROKER:
------------------------------------------------------------------------------------------
Joint Broker - Sanlam Securities UK Limited,10 King William
Street, London EC4N 7TW
Joint Broker - Peterhouse Corporate Finance Limited, 31 Lombard
Street, London EC3V 9BQ
------------------------------------------------------------------------------------------
OTHER THAN IN THE CASE OF A QUOTED APPLICANT, DETAILS OF WHERE
(POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE
AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL
DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:
------------------------------------------------------------------------------------------
Sanlam Securities UK Limited,10 King William Street, London
EC4N 7TW
The admission document containing full details regarding the
applicant and admission of its securities will be available
from the Company's website www.fbk.com.
------------------------------------------------------------------------------------------
DATE OF NOTIFICATION:
------------------------------------------------------------------------------------------
30 April 2014
------------------------------------------------------------------------------------------
NEW/ UPDATE:
------------------------------------------------------------------------------------------
NEW
------------------------------------------------------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
PAAWGURWCUPCURU
Feedback (LSE:FDBK)
過去 株価チャート
から 7 2024 まで 8 2024
Feedback (LSE:FDBK)
過去 株価チャート
から 8 2023 まで 8 2024